David A Albaugh

Title: Innovator Spotlight: David A. Albaugh and His Contributions to Antifungal Compounds

Introduction: David A. Albaugh is a notable inventor based in Trenton, NJ, whose work has significantly contributed to the field of antifungal agents. With a sole patent to his name, Albaugh demonstrates a commitment to innovation within his industry. His research focuses on developing new compounds that help combat fungal infections, showcasing his expertise and dedication to improving public health.

Latest Patents: Albaugh holds a patent for "Fungicidal agents LL-15G256.gamma., delta., and epsilon." This invention introduces new antifungal compounds of Formula I or II, where specific compounds are derived from culture LL-15G256 (Hypoxylon oceanicum), NRRL 21363. These compounds are produced through fermentation, emphasizing their potential as effective antifungal agents.

Career Highlights: Working at the American Cyanamid Company, David A. Albaugh has established a solid career that emphasizes the practical application of scientific research. His patent reflects not only his technical knowledge but also his ability to translate that knowledge into viable products for the market.

Collaborations: Throughout his career, Albaugh has collaborated with colleagues such as Gerhard Schlingmann and Lisa Milne. These partnerships not only enhance the scope of his work but also highlight the importance of teamwork in the field of innovation and patent development.

Conclusion: David A. Albaugh's contributions to the development of antifungal compounds represent a significant advancement in medicinal chemistry. With his work at the American Cyanamid Company and his innovative patent, Albaugh exemplifies the role of inventors in enhancing public health and pushing the boundaries of scientific research. His collaborations and dedication continue to inspire future innovations in the field.